Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors
Haider A, Pacher P, Herde A, Spinelli F, Ahmed H, Atz K, Keller C, Weber M, Schibli R, Mu L, Grether U, Knuesel I, Bartelmus C, Gobbi L, Kretz J, Ullmer C, Brink A, Honer M, Woltering T, Muri D, Iding H, Bürkler M, Binder M, Ametamey S. Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors. J Med Chem 2020; 63:10287-10306.
Sep 1, 2020
Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors
Sep 1, 2020
J Med Chem 2020; 63:10287-10306
Haider Ahmed, Pacher Pal, Herde Adrienne Müller, Spinelli Francesco, Ahmed Hazem, Atz Kenneth, Keller Claudia, Weber Markus, Schibli Roger, Mu Linjing, Grether Uwe, Knuesel Irene, Bartelmus Christian, Gobbi Luca, Kretz Julian, Ullmer Christoph, Brink Andreas, Honer Michael, Woltering Thomas J, Muri Dieter, Iding Hans, Bürkler Markus, Binder Martin, Ametamey Simon M
more
